# Executive Evidence Summary: Biological Countercurvature

**Date Generated:** 2026-04-12
**Source Data Baseline:** `outputs/afcc/2026-02-16/metrics.csv`

## 1. What is Stronger Now Than Baseline
Through explicit confidence-weighting and data-freshness auditing, we have established a much more rigorous baseline for evaluating AlphaFold-derived structural evidence.
*   **Confirmed Mechanostructural Anchors:** We have isolated true high-confidence, high-anisotropy proteins (`PIEZO2`, `FBLN5`, `CNNM2`, `STOML3`, `PANX3`). These represent the most robust foundation for the hypothesis that specific spinal genes encode highly extended, physical load-bearing or tension-sensing geometries.
*   **Analytical Discipline:** By separating measured data from narrative inference, we confirmed that `LBX1` is definitively an intermediate-anisotropy, highly modular, but low-confidence structure. This bounds the claims we can make about it—it is *not* a rigid tension rod like `PIEZO2`.
*   **Identified Narrative Artifacts:** The freshness audit (`reports/evidence_freshness_audit.md`) successfully identified that longitudinal "trends" or "emerging classes" described in recent cluster notes were narrative artifacts applied to completely static underlying data vectors.

## 2. What Remains Weak (Evidence AGAINST / Weakening the Hypothesis)
The central vulnerability of the current structural argument lies in the over-interpretation of low-confidence predictions.
*   **The Disordered Rod Problem:** Several of the most extreme anisotropic proteins (e.g., `POC5`, `GHR`, `EMD`) have poor pLDDT scores (<65). It is highly plausible that their "extended fibrous" shape in the model is an artifact of AlphaFold linearly projecting intrinsically disordered regions, rather than predicting true functional biological stiffness.
*   **LBX1 as a Direct Mechanical Transducer:** The structural metrics alone provide no direct evidence that `LBX1` transmits force. Its low structural confidence and intermediate shape suggest it may simply be a standard transcription factor, meaning its link to countercurvature may be purely biochemical.
*   **Lack of Functional Validation:** We have static geometric predictions, but no dynamic data proving these geometries possess mechanical stiffness or change conformation under tension.

## 3. Top 3 Highest-Leverage Next Experiments
To transition the countercurvature hypothesis from computational speculation to biological mechanism, the following experiments (derived from the falsifiability plan) are required:

1.  **Biophysical Stiffness Assays for High-Anisotropy Candidates:** Perform Atomic Force Microscopy (AFM) pulling on isolated domains of both high-confidence (PIEZO2) and low-confidence (POC5) anisotropic proteins. *Goal: Prove that predicted extended geometries actually possess mechanical resistance (stiffness) rather than behaving as random coils.*
2.  **LBX1 Tension-Localization Screen:** Subject primary somite/muscle cells expressing tagged LBX1 to cyclical mechanical stretch. *Goal: Test if LBX1 directly translocates or clusters in response to physical force, differentiating a mechanical role from a purely developmental one.*
3.  **Traction Force Microscopy of LBX1 Mutants:** Express truncated "blocky" mutants of LBX1 (retaining the DNA-binding domain but losing AlphaFold-predicted modular domains) and measure cellular traction forces. *Goal: Determine if the non-transcriptional geometry of LBX1 is necessary for mechanical outputs at the cellular level.*
